These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 26803538)

  • 1. Incapacitating solar urticaria: successful treatment with omalizumab.
    Kieselova K; Santiago F; Henrique M
    An Bras Dermatol; 2019 Jul; 94(3):331-333. PubMed ID: 31365663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Omalizumab changed my life': a patient perspective on solar urticaria.
    Parkin D; Ling TC; Ayer J; Rhodes LE; Rutter KJ
    Clin Exp Dermatol; 2024 Jul; 49(8):935-936. PubMed ID: 38491908
    [No Abstract]   [Full Text] [Related]  

  • 3. Indication of Omalizumab for Chronic Urticaria Using the 'Urticaria Control Test' Instead of 'Urticaria Activity Score': Possible Impact for Health Systems.
    Sánchez J; Alvarez L; López JF
    Actas Dermosifiliogr; 2024 Jan; 115(1):T88-T90. PubMed ID: 37871896
    [No Abstract]   [Full Text] [Related]  

  • 4. Indication of Omalizumab for Chronic Urticaria Using the 'Urticaria Control Test' Instead of 'Urticaria Activity Score': Possible Impact for Health Systems.
    Sánchez J; Alvarez L; López JF
    Actas Dermosifiliogr; 2024 Jan; 115(1):88-90. PubMed ID: 36754254
    [No Abstract]   [Full Text] [Related]  

  • 5. Urticaria Control Test real-world performance: A post-hoc analysis.
    Salameh P; Gutsche A; Aulenbacher F; Buttgereit T; Weller K; Siebenhaar F; Maurer M
    Allergy; 2024 Jan; 79(1):229-232. PubMed ID: 37439320
    [No Abstract]   [Full Text] [Related]  

  • 6. Case of postural urticaria in a 14-year-old girl.
    Gabrielli S; Le M; Netchiporouk E; Ben-Shoshan M
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34711626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab for the Treatment of Refractory Acute Urticaria.
    Wang S; Chen X; Bai J; Sun Q; Qiao J; Fang H
    Am J Ther; 2024 Jul-Aug 01; 31(4):e487-e489. PubMed ID: 38976536
    [No Abstract]   [Full Text] [Related]  

  • 8. An approach to the patient with urticaria.
    Deacock SJ
    Clin Exp Immunol; 2008 Aug; 153(2):151-61. PubMed ID: 18713139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful ligelizumab treatment of severe refractory solar urticaria.
    Hershkovitz Y; Khanimov I; Rubin L; Dranitzki Z; Talmon A; Ribak Y; Shamriz O; Levi A; Tal Y
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2576-2577. PubMed ID: 36796509
    [No Abstract]   [Full Text] [Related]  

  • 10. Omalizumab for severe allergic keratoconjunctivitis: A case series.
    Mercier M; Doan S; Elaouane I; Chelly Z; Bourgoin-Heck M; Lambert N; Cottel N; Taillé C; Wanin S
    J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3528-3530. PubMed ID: 37482081
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM).
    McComish JS; Slade CA; Buizen L; Paul SK; Chatelier JW; Unglik G; Nicholls KA; Spriggs K; Chan SS; Godsell J; Auyeung P; Tan ZH; DeLuca J; Patel M; Kuek LE; Tran Y; Kern JS; Scardamaglia L; Varigos GA; Juneja S; Grabek JA; Christie M; Mackay GA; Douglass JA
    J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2248-2250.e3. PubMed ID: 37088371
    [No Abstract]   [Full Text] [Related]  

  • 12. Solar Urticaria and Omalizumab: A Retrospective Case-Control Study and Follow-Up.
    Casanova-Esquembre A; Lorca-Spröhnle J; Peñuelas-Leal R; Pérez-Ferriols A
    Actas Dermosifiliogr; 2024 Mar; ():. PubMed ID: 38452893
    [No Abstract]   [Full Text] [Related]  

  • 13. Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study.
    Aubin F; Avenel-Audran M; Jeanmougin M; Adamski H; Peyron JL; Marguery MC; Léonard F; Puyraveau M; Viguier M;
    J Am Acad Dermatol; 2016 Mar; 74(3):574-5. PubMed ID: 26892659
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change.
    Ertas R; Ozyurt K; Atasoy M; Hawro T; Maurer M
    Allergy; 2018 Mar; 73(3):705-712. PubMed ID: 29083482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to Omalizumab in Solar Urticaria: Report of 3 Cases.
    Rodríguez-Jiménez P; Chicharro P; Pérez-Plaza A; de Argila D
    Actas Dermosifiliogr; 2017 Oct; 108(8):e53-e55. PubMed ID: 28457471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study.
    Sheldon E; Schwickart M; Li J; Kim K; Crouch S; Parveen S; Kell C; Birrell C
    Adv Ther; 2016 Feb; 33(2):225-51. PubMed ID: 26843086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of aquagenic urticaria successfully treated with omalizumab.
    Rorie A; Gierer S
    J Allergy Clin Immunol Pract; 2016; 4(3):547-8. PubMed ID: 26852068
    [No Abstract]   [Full Text] [Related]  

  • 18. Photodermatitis for the Allergist.
    Coffin SL; Turrentine JE; Cruz PD
    Curr Allergy Asthma Rep; 2017 Jun; 17(6):36. PubMed ID: 28477263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of omalizumab in severe solar urticaria.
    de Dios-Velázquez Á; González-de Arriba M; Beteta-Gorriti V; Macías E; Campanón-Toro V; Dávila I
    Ann Allergy Asthma Immunol; 2016 Mar; 116(3):260-2. PubMed ID: 26803538
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.